Search clinical trials for: Salmon protein

Total 22356 results

Medical University of Gdansk

Completed

Optimalization of Nephroprotection Using N-Acetylcysteine

Proteinuria | Chronic Kidney Disease
Medical University of Gdansk

Completed

Optimalization of Nephroprotection Using Atorvastatin (Sortis)

Proteinuria | Chronic Kidney Disease
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B

Hemophilia B | Allergic Reactions

France, Italy, United States, Austria, Belgium, Spain, United Kingdom, Canada, Germany
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R) in Moderate to Severe Hemophilia B

Hemophilia B
Boston Children's Hospital
National Institutes of Health (NIH); Crohn's and Colitis Foundation

Completed

Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease

Crohn's Disease | Ulcerative Colitis

United States
Shanghai Municipal Health Bureau

Unknown

Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3 (FLIP)

Proteinuria | Angiotensin II Type 1 Receptor Blockers | Chronic Kidney Insufficiency | Angiotensin-Converting Enzyme Inhibitors

China
Peking University

Completed

G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical Response

Amyotrophic Lateral Sclerosis

China
Assistance Publique - Hôpitaux de Paris

Completed

Evaluation of the Effectiveness of a Protein Pulse-Feeding Pattern in Elderly Patients (PRO-PULSé)

Protein-Energy Malnutrition

France
Dartmouth-Hitchcock Medical Center
Celgene Corporation

Completed

Phase II Study Using Thalidomide for the Treatment of ALS

Amyotrophic Lateral Sclerosis | ALS

United States
AO Clinical Investigation and Publishing Documentation
Ossacur Inc.

Terminated

Open Wedge High Tibia Osteotomy

High Tibia Osteotomy

Switzerland, Germany
Novartis

Completed

Effects of Imatinib in Subjects With Seasonal Allergic Rhinitis and Who Are Sensitive to Timothy Grass Pollen

Seasonal Allergic Rhinitis

United Kingdom
Solvay Pharmaceuticals

Completed

Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension

Hypertension

Italy
Shiraz University of Medical Sciences

Completed

Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy

Diabetic Nephropathy | Chronic Kidney Disease | Diabetes Type 2

Iran, Islamic Republic of
Johns Hopkins University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Noninvasive Ventilation in ALS Patients With Mild Respiratory Involvement

Amyotrophic Lateral Sclerosis

United States
Institut de Recherches Cliniques de Montreal

Terminated

Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes

Hypertension | Type 2 Diabetes | Albuminuria

Canada
Isfahan University of Medical Sciences
Shahid Beheshti University of Medical Sciences

Completed

Long-Term Effect of Soy Consumption on Cardio-Renal Indices and CRP in Type 2diabetes With Nephropathy

Kidney Transplantation
Novacea
Schering-Plough

Suspended

A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer

Pancreatic Cancer

United States
Gruppo Italiano MEsotelioma

Unknown

A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant Mesothelioma

Mesothelioma

Italy
University of Wuerzburg

Unknown

Multi Centre Trial of DSMM for Newly Diagnosed Multiple Myeloma up to 60 Years

Multiple Myeloma

Germany, Austria
Johann Wolfgang Goethe University Hospital

Unknown

Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL)

Philadelphia Positive Acute Lymphoblastic Leukemia | Lymphoid Blastic Phase of Chronic Myeloid Leukemia

Germany
Inflabloc Pharmaceuticals

Completed

An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's Disease

Crohn's Disease

United States, Canada
Kamada, Ltd.

Completed

Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency (Kamada API)

Alpha 1-Antitrypsin Deficiency

United States
Recoly N.V.

Completed

Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes.

Haemophilia A

Russian Federation
Eli Lilly and Company

Completed

A Study of the Treatment of Postmenopausal Women With Osteoporosis

Osteoporosis, Post-Menopausal

China
Eli Lilly and Company

Completed

PTH Comparison in Post Menopausal Women

Osteoporosis, Post-Menopausal

Taiwan
Eli Lilly and Company

Completed

Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis

Osteoporosis, Postmenopausal

Korea, Republic of
Sanofi

Completed

CARE Canadian ALS Riluzole Evaluation

Amyotrophic Lateral Sclerosis

Canada
Sheba Medical Center

Unknown

Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy

Leukemia, Myeloid, Philadelphia-Positive

Israel
Pfizer

Completed

Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery

Venous Thrombosis

Australia, United States, Spain, Czech Republic, Portugal, Canada, South Africa, Italy, Colombia, Poland, France, Chile, Russian Federation, Denmark, United Kingdom, Slovakia
Sanofi

Completed

A Pilot, Multi-Center, Patient Preference Study Comparing Two Clindamycin/Benzoyl Peroxide Gels.

Acne Vulgaris
Speedel Pharma Ltd.
Quintiles, Inc.

Completed

A Clinical Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Heparin in Patients Who Are on Haemodialysis

Chronic Kidney Failure | Vascular Graft Occlusion

United States
Octagen Corporation
Biomeasure Inc, Ipsen Group

Completed

Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIII

Hemophilia A

United States
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck

Carcinoma, Adenoid Cystic | Cancer of the Head and Neck

France
National Cancer Institute (NCI)

Completed

Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation

Multiple Myeloma | Graft vs Host Disease

United States
Medical University of Gdansk

Completed

Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System

Proteinuria | Chronic Kidney Disease
Prothya Biosolutions

Completed

Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX)

Hemophilia B

Netherlands
AstraZeneca
Mexican National Institute of Public Health

Completed

C-Reactive Protein (CRP) in Obese Diabetic Women

Diabetes Mellitus, Type 2

Mexico
The Medicines Company

Completed

Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS)

Myocardial Infarction | Acute Disease | Unstable Angina

United States
Health Enhancement Products, Inc.
MAPS Applied Research Center

Unknown

The Effects of ProAlgaZyme on HDL Cholesterol in Individuals With Metabolic Syndrome

Metabolic Syndrome | Hyperlipidemia

United States
University of Toronto

Completed

Effect of Replacing HFCS With Sucromalt in Subjects With Raised Waist Circumference

Abdominal Obesity

Canada
University of Bologna
Novartis

Completed

Imatinib Standard Dose (400 mg/Day) Versus Imatinib High Dose (800 mg/Day) (CML022)

Chronic Myeloid Leukemia

Italy
University of Bologna

Completed

Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia in Accelerated and Blastic Phase (CML003)

Chronic Myeloid Leukemia

Italy
University of Aarhus

Completed

Growth Hormone Signaling in Vivo in Humans

Intracellular Signaling Peptides and Proteins

Denmark
University of Bologna
Novartis; Schering-Plough

Terminated

Study of the Combination of a Tyrosine Kinase Inhibitor (STI571) and a Pegylated Human Recombinant Interferon alfa2b (PEGINTRON)

Chronic Myeloid Leukemia
University of Bologna
Novartis

Completed

Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia

Chronic Myeloid Leukemia
University of Bologna

Completed

Exploratory Study of IMATINIB High Dose in Intermediate Risk Chronic Myeloid Leukemia in Chronic Phase

Myeloid Leukemia, Chronic, Chronic-Phase

Italy
Sundsvall Hospital

Completed

Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders.

Multiple Myeloma | Anemia | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma

Sweden
National Taiwan University Hospital

Completed

Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

Taiwan
Ottawa Hospital Research Institute

Completed

High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB Therapy

Diabetic Kidney Disease

Canada
Weill Medical College of Cornell University

Terminated

Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer

Head and Neck Cancer

United States

Search clinical trials for: Salmon protein

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations